Novel BBB-Surpassing Peptide Structure for Unlocking New Treatment Avenues
Time: 2:00 pm
day: Conference Day 1
Details:
- Developing peptide-based drugs for the treatment of affective disorders
- Peptides derived from natural genomic sequences with low toxicity and the ability to surpass the blood-brain-barrier
- Exploring PTIs lead compound, PT00114, which is currently in clinical trials
